BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15736181)

  • 41. The influence of image magnification in first-trimester screening for Down syndrome by fetal nuchal translucency in Asians.
    Hsu JJ; Chiang CH; Hsieh CC; Hsieh TT
    Prenat Diagn; 2004 Dec; 24(12):1007-12. PubMed ID: 15614833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
    Chasen ST; Sharma G; Kalish RB; Chervenak FA
    Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First trimester umbilical artery pulsatility index in fetuses presenting enlarged nuchal translucency.
    Zoppi MA; Ibba RM; Putzolu M; Floris M; Monni G
    Prenat Diagn; 2000 Sep; 20(9):701-4. PubMed ID: 11015696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
    Lam YH; Tang MH; Lee CP; Tse HY
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abnormal first-trimester ductus venosus blood flow: a risk factor for adverse outcome in fetuses with normal nuchal translucency.
    Oh C; Harman C; Baschat AA
    Ultrasound Obstet Gynecol; 2007 Aug; 30(2):192-6. PubMed ID: 17518423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan.
    Becker R; Wegner RD
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):613-8. PubMed ID: 16570262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
    Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
    Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
    Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distribution of normal nuchal translucency thickness: a multicenter study in Thailand.
    Kor-Anantakul O; Suntharasaj T; Suwanrath C; Chanprapaph P; Sirichotiyakul S; Ratanasiri T; Vuthiwong C; Geater A
    Gynecol Obstet Invest; 2011; 71(2):124-8. PubMed ID: 21150163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
    Soergel P; Pruggmayer M; Schwerdtfeger R; Muhlhaus K; Scharf A
    Fetal Diagn Ther; 2006; 21(3):264-8. PubMed ID: 16601335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of tissue harmonic imaging on measurement of nuchal translucency thickness.
    Pasquini L; Tondi F; Rizzello F; Pontello V; Paoletti E; Fontanarosa M
    Ultrasound Obstet Gynecol; 2010 Oct; 36(4):423-6. PubMed ID: 20205154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.
    Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G
    Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimal crown-rump length for measuring the nuchal translucency.
    Wax JR; Pinette MG; Cartin A; Blackstone J
    J Clin Ultrasound; 2007; 35(6):302-4. PubMed ID: 17486568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
    Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
    Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of critical congenital heart defects by nuchal translucency norms.
    Jelliffe-Pawlowski LL; Norton ME; Shaw GM; Baer RJ; Flessel MC; Goldman S; Currier RJ
    Am J Obstet Gynecol; 2015 Apr; 212(4):518.e1-10. PubMed ID: 25448520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.
    Maiz N; Plasencia W; Dagklis T; Faros E; Nicolaides K
    Ultrasound Obstet Gynecol; 2008 Mar; 31(3):256-60. PubMed ID: 18307193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Congenital diaphragmatic hernia in a first-trimester ultrasound aneuploidy screening program.
    Sepulveda W; Wong AE; Casasbuenas A; Solari A; Alcalde JL
    Prenat Diagn; 2008 Jun; 28(6):531-4. PubMed ID: 18509856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measurement of nuchal volume in the first trimester Down screening using three-dimensional ultrasound.
    Shaw SW; Hsieh TT; Hsu JJ; Lee CL; Cheng PJ
    Prenat Diagn; 2009 Jan; 29(1):69-73. PubMed ID: 19090500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.